Calculate Your Salary Ranking
Home > Advaxis Salary

Advaxis Salary
  • 76
  • 62
  • 65

Advaxis average salary is $100,750, median salary is $65,000 with a salary range from $65,000 to $208,000.
Advaxis salaries are collected from government agencies and companies. Each salary is associated with a real job position. Advaxis salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 2 Advaxis Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
Senior Research Scientist 65,000-65,000 North Brunswick, NJ, 08902 2010 Advaxis Senior Research Scientist Salaries (3)
Advaxis North Brunswick, NJ Salaries
Chief Financial Officer 208,000-208,000 Princeton, NJ, 08540 2010 Advaxis Chief Financial Officer Salaries (1)
Advaxis Princeton, NJ Salaries
Advaxis Jobs
See more Advaxis Jobs »
  • Scientist, Process Development
    We are seeking an individual with technical experience in process development and process analytical development of biotechnology products. This individual
  • Lab Manager
    SUMMARY OF POSITION: Looking for a highly motivated individual with significant experience in managing daily lab operations, basic cell, microbiology and
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent Advaxis Salaries (October 20, 2016)
Assistant Professor University of Oklahoma $42,860 Norman, OK, 73019 01/05/2015
General OMRON $65,998 Houston, TX, 77001 09/07/2015

Advaxis salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Advaxis Information
  • Advaxis Inc
  • Industry: Biotech/Healthcare
  • City: North Brunswick, NJ
  • Advaxis, Inc. is a biotechnology company based upon the concept that in order to treat cancer and other diseases immunologically it is best to use a modified infectious micro-organism to elicit the most profound immune response possible, as this is what the immune system evolved to address. Based upon over a 10 years of innovative work done by Yvonne Paterson, Ph.D., Professor of Microbiology at the University of Pennsylvania, it has been found that the unique microbe Listeria monocytogenes is capable of simultaneously stimulating every numerous aspects of the immune sys.tem simultaneously; thus coordinating innate, humoral (antibody), and cellular adaptive